Core Insights - CareCloud, Inc. will release its financial results for the second quarter ended June 30, 2025, before the market opens on August 5, 2025 [1] - A conference call for investors will follow at 8:30 a.m. Eastern Time on the same day [1] Company Overview - CareCloud is a leader in AI-powered healthcare technology and revenue cycle management solutions, serving medical practices and health systems across the nation [1] - The company offers a suite of solutions aimed at improving financial and operational performance, streamlining clinical workflows, and enhancing patient experience [4] - More than 40,000 providers rely on CareCloud to improve patient care while reducing administrative burdens and operating costs [4]

Core Insights - CareCloud, Inc. has been added to the Russell Microcap® Index, effective June 30, 2025, highlighting its growing recognition in the healthcare technology sector [1][3] - The company's common stock price increased by approximately 70% during Q2 2025, driven by key developments including the launch of an AI Center of Excellence and a strong cash position of around $10 million [2] Company Developments - The launch of CareCloud's AI Center of Excellence is a significant milestone aimed at enhancing its technological capabilities [2] - The company resumed acquisition activities in targeted growth areas, indicating a strategic focus on expansion [2] - Approximately 3.5 million shares of Series A Preferred Stock were converted into Common Stock on March 6, 2025, reflecting a shift in capital structure [2] Financial Performance - CareCloud reported a strong cash position of approximately $10 million at the end of Q2 2025, which supports its operational and strategic initiatives [2] - The inclusion in the Russell Microcap Index serves as a benchmark for performance in the U.S. small-cap equity market, potentially attracting more institutional investors [3]

Core Insights - CareCloud, Inc. has launched its AI Center of Excellence (AI CoE), aimed at delivering scalable, domain-specific AI solutions for healthcare [1][2] - The AI CoE began operations with a team of over 50 professionals and plans to expand to 500 by Q4 2025, positioning itself as the largest dedicated healthcare AI initiative globally [2][3] - The initiative is fully self-funded, showcasing CareCloud's strong cash flows and efficient cost structure, which allows for accelerated innovation and cost-effective solutions [2][4] Company Strategy - The AI CoE is a pivotal part of CareCloud's growth strategy, emphasizing the need for innovation in the healthcare sector to remain competitive [3][5] - CareCloud aims to integrate AI across its technology stack, enhancing operational efficiency and clinical outcomes while reducing administrative burdens [4][5] - The company is focused on developing proprietary healthcare AI models, streamlining clinical workflows, and improving patient engagement through AI-driven personalization [7] Industry Impact - The healthcare industry is rapidly adopting AI, and CareCloud's AI CoE is positioned to lead this transformation by driving operational changes and improving care delivery [5][6] - By leveraging 25 years of clinical and financial data, CareCloud is developing AI solutions that are compliant with HIPAA regulations, ensuring immediate real-world impact [2][4] - The focus on predictive analytics will enable earlier identification of reimbursement risks and operational bottlenecks, further enhancing the efficiency of healthcare providers [7]